Michael G. DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Division of Cardiovascular Surgery, Department of Surgery, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
J Thorac Cardiovasc Surg. 2018 Jul;156(1):5-13.e1. doi: 10.1016/j.jtcvs.2018.02.094. Epub 2018 Mar 13.
Whether the aortopathy associated with bicuspid aortic valve (BAV) disease occurs secondary to genetic or hemodynamic factors remains controversial. In this article we describe the natural history of the aortic root in patients with bicuspid versus tricuspid aortic valves (TAVs) after replacement of the aortic valve and ascending aorta.
From 1990 to 2010, 406 patients (269 BAV, 137 TAV) underwent aortic valve and ascending aorta replacement at a single institution. Patients with aortic dissection, endocarditis, previous aortic surgery, or Marfan syndrome were excluded. All available follow-up imaging was reviewed.
Mean imaging follow-up was 5.5 (±5.3) years. Of all patients, 66.5% had at least 1 aortic root measurement after the index operation. Baseline aortic diameter was comparable between groups. In patients with BAV, aortic root diameter increased at a clinically negligible rate over time (0.654 mm per year; 95% confidence interval, 0.291-1.016; P < .001), similar to patients with TAV (P = .92). Mean clinical follow-up was 8.1 (±5.4) years. During follow-up, 18 patients underwent reoperation, 89% for a degenerated bioprosthetic aortic valve. Only 1 patient underwent reoperation for a primary indication of aortic aneurysmal disease, 22 years after the index operation. There were no differences in cumulative incidence rates of aortic reoperation (P = .14) between patients with BAV and TAV.
Mid-term imaging after aortic valve and ascending aorta replacement indicates that if the aortic root is not dilated at the time of surgery, the risk of enlargement over time is minimal, negating the need for prophylactic root replacement in patients with BAV or TAV.
二叶式主动脉瓣(BAV)疾病相关的升主动脉病变是由遗传因素还是血流动力学因素引起,目前仍存在争议。本文旨在描述二叶式主动脉瓣(BAV)与三叶式主动脉瓣(TAV)患者主动脉瓣及升主动脉置换术后主动脉根部的自然病程。
1990 年至 2010 年,在单中心共 406 例患者(BAV 269 例,TAV 137 例)接受了主动脉瓣及升主动脉置换术。排除主动脉夹层、感染性心内膜炎、既往主动脉手术或马凡综合征患者。回顾所有可获取的随访影像学资料。
平均影像学随访时间为 5.5(±5.3)年。所有患者中,66.5%在指数手术后至少有 1 次主动脉根部测量。两组患者的基线主动脉直径相似。BAV 患者的主动脉根部直径随时间呈临床可忽略的速度增加(每年 0.654mm;95%置信区间,0.291-1.016;P<0.001),与 TAV 患者相似(P=0.92)。平均临床随访时间为 8.1(±5.4)年。随访期间,18 例患者接受了再次手术,89%为退行性生物瓣主动脉瓣置换。仅 1 例患者因指数手术后 22 年主动脉瘤样病变的主要指征而接受再次手术,无主动脉再手术的累积发生率差异(P=0.14)。
主动脉瓣及升主动脉置换术后中期影像学检查表明,如果手术时主动脉根部不扩张,随着时间的推移,主动脉根部增大的风险极小,因此对于 BAV 或 TAV 患者,无需预防性行根部置换术。